Accunovo Biotechnologies Inc.

Chapel Hill, NC

UEI
DAF9XL6P2BG5
CAGE
8FAR0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
211 Lake Manor Rd, Chapel Hill, NC 27516, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Theranostic NTSR1-targeting agents for complementary management of psma-negative prostate cancer R43CA261503 National Cancer Institute (NIH) $752,894

Quick answers

Is Accunovo Biotechnologies Inc. registered in SAM.gov?

Yes. Accunovo Biotechnologies Inc.'s SAM.gov registration is active through November 11, 2026.

What is Accunovo Biotechnologies Inc.'s most recent federal award?

Accunovo Biotechnologies Inc.'s most recent federal grant award is Theranostic NTSR1-targeting agents for complementary management of psma-negative prostate cancer (R43CA261503), from National Cancer Institute (NIH), on April 5, 2022.

On GovTribe

See Accunovo Biotechnologies Inc.'s full federal record

  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login